Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

(2021) Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

Full text not available from this repository.

Abstract

The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis (MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients, number of relapses in pre-defined at risk-period (ARP) was compared with the previous two years. During the previous two years, a total of 32 attacks was reported, which 5 (15.6) were during the at-risk period. After adjusting for age and sex, there was an increased risk of attack during ARP compared to the previous two years (RR: 2.566, 95CI: 1.075-6.124, P=0.034). Our preliminary study suggested that COVID-19 can trigger exacerbation of MS.

Item Type: Article
Keywords: Multiple sclerosis Coronavirus Infection Relapse Exacerbation INFECTIONS
Journal or Publication Title: Multiple Sclerosis and Related Disorders
Journal Index: ISI
Volume: 52
Identification Number: https://doi.org/10.1016/j.msard.2021.102947
ISSN: 2211-0348
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/14150

Actions (login required)

View Item View Item